×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

AEON Biopharma Inc.. (AEON) NYSE MKT LLC

$1.53 0.03 (2.00%)

Market Cap: $59.86M

As of 05/17/24 04:00 PM EDT. Market closed.

(AEON)

AEON Biopharma Inc.. (AEON)
NYSE MKT LLC

$1.53
0.03 (2.00%)

Market Cap: $59.86M

As of 05/17/24 04:00 PM EDT. Market closed.

Add to Portfolio

we are a nasdaq-listed special purpose acquisition company whose business purpose is to effect a merger or similar business combination with one or more businesses. our acquisition strategy is to identify and complete our initial business combination with a medical technology company in the healthcare industry. our sponsor team consists of chairman/ceo robert palmisano, president vikram malik, ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
3
URL
Address
.
PRICE CHART FOR AEON BIOPHARMA INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.53
Previous Close
$1.50
Days Range
$1.47 - $1.61
52 week range
$1.38 - $17.17
Volume
68,491
Avg. Volume (30 days)
133,156
Market Cap
$59.86M
Dividend Yield
-
P/E
-
Shares Outstanding
39,122,238
Open
$1.53
Previous Close
$1.50
Days Range
$1.47 - $1.61
52 week range
$1.38 - $17.17
Volume
68,491
Avg. Volume (30 days)
133,156
Market Cap
$59.86M
Dividend Yield
-
P/E
-
Shares Outstanding
39,122,238
FINANCIAL STATEMENTS FOR AEON BIOPHARMA INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AEON BIOPHARMA INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Strathspey Crown Holdings Group, LLC10% OwnerAug 11, 2023 Sale$10.007,380,39473,803,9402,031,773Aug 14, 2023, 04:10 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Strathspey Crown Holdings Group, LLC10% Owner08/11/202373,803,940
FUNDS WITH A POSITION IN AEON BIOPHARMA INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.255,4230.00007%3.37%Other
GEODE CAPITAL MANAGEMENT, LLC179,5950.00019%4.27%Other
DUPONT CAPITAL MANAGEMENT CORP30%No changeOther
CHANGE IN SHARES OUTSTANDING FOR AEON BIOPHARMA INC.
STOCK BUYBACKS FOR AEON BIOPHARMA INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0%
1Q
12/31/2023
09/30/2022
-73.24%
5Q
12/31/2023
06/30/2022
-73.23%
6Q
12/31/2023
03/31/2022
7.71%
7Q
12/31/2023
12/31/2021
-70.57%
8Q
12/31/2023
09/30/2021
7.71%
9Q
12/31/2023
06/30/2021
7.71%
10Q
12/31/2023
03/31/2021
69.47%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0%
1Q
09/30/2022
-73.24%
5Q
06/30/2022
-73.23%
6Q
03/31/2022
7.71%
7Q
12/31/2021
-70.57%
8Q
09/30/2021
7.71%
9Q
06/30/2021
7.71%
10Q
03/31/2021
69.47%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AEON BIOPHARMA INC.
LOADING...